MONT-SAINT-HILAIRE, QUEBEC -- (MARKET WIRE) -- January 31, 2007 -- Axcan Pharma Inc. (“Axcan” or the “Company”) (TSX: AXP)(NASDAQ: AXCA) today announced that on Tuesday, February 6, 2007, President and Chief Executive Officer, Frank Verwiel, M.D., will present an overview of the Company at the Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference to be held in New York. This presentation will take place at 10.20 a.m. Eastern time.
